Computational	O
Modeling	O
of	O
β-	B:C1569775
Secretase	I:C1569775
1	I:C1569775
(	O
BACE	B:C1569775
-	I:C1569775
1	I:C1569775
)	O
Inhibitors	B:C0243077
Using	O
Ligand	B:C0025663
Based	I:C0025663
Approaches	I:C0025663
.	O

The	O
binding	B:C1167622
affinities	O
(	O
IC50	O
)	O
reported	O
for	O
diverse	O
structural	B:C0678594
and	O
chemical	B:C0220806
classes	O
of	O
human	B:C1569775
β-	I:C1569775
secretase	I:C1569775
1	I:C1569775
(	O
BACE	B:C1569775
-	I:C1569775
1	I:C1569775
)	O
inhibitors	B:C0243077
in	O
literature	B:C0023866
were	O
modeled	O
using	O
multiple	O
in	O
silico	O
ligand	B:C0870071
based	I:C0870071
modeling	I:C0870071
approaches	I:C0870071
and	O
statistical	B:C1710191
techniques	I:C1710191
.	O

The	O
descriptor	B:C0282354
space	O
encompasses	O
simple	O
binary	O
molecular	O
fingerprint	O
,	O
one	O
-	O
and	O
two	B:C1705052
-	I:C1705052
dimensional	I:C1705052
constitutional	O
,	O
physicochemical	O
,	O
and	O
topological	B:C0282354
descriptors	I:C0282354
,	O
and	O
sophisticated	O
three	B:C0450363
-	I:C0450363
dimensional	I:C0450363
molecular	O
fields	O
that	O
require	O
appropriate	O
structural	B:C0678594
alignments	O
of	O
varied	O
chemical	B:C0220806
scaffolds	I:C0220806
in	O
one	O
universal	O
chemical	O
space	O
.	O

The	O
affinities	O
were	O
modeled	O
using	O
qualitative	O
classification	B:C0008902
or	O
quantitative	O
regression	B:C0034980
schemes	I:C0034980
involving	O
linear	B:C0205132
,	O
nonlinear	O
,	O
and	O
deep	B:C0870951
neural	I:C0870951
network	I:C0870951
(	O
deep	B:C0870951
neural	I:C0870951
network	I:C0870951
)	O
machine	O
-	O
learning	O
methods	B:C0025663
used	O
in	O
the	O
scientific	O
literature	B:C0023866
for	O
quantitative	O
-	O
structure	O
activity	O
relationships	O
(	O
QSAR	O
)	O
.	O

In	O
a	O
departure	O
from	O
tradition	O
,	O
∼	O
20	O
%	O
of	O
the	O
chemically	B:C0220806
d	O
iverse	O
data	B:C0150098
set	I:C0150098
(	O
205	O
compounds	B:C1706082
)	O
was	O
used	O
to	O
train	O
the	O
model	B:C3161035
with	O
the	O
remaining	O
∼	O
80	O
%	O
of	O
the	O
s	O
tructural	B:C0678594
and	O
chemical	B:C0220806
analogs	B:C0243071
used	O
as	O
part	O
of	O
an	O
external	B:C0205101
validation	B:C1519941
(	O
1273	O
compounds	B:C1706082
)	O
and	O
prospective	B:C0033522
test	I:C0033522
(	O
69	O
compounds	B:C1706082
)	O
sets	O
respectively	O
to	O
ascertain	O
the	O
model	B:C3161035
performance	O
.	O

The	O
machine	O
-	O
learning	O
methods	B:C0025663
investigated	O
herein	O
performed	O
well	O
in	O
both	O
the	O
qualitative	O
classification	B:C0008902
(	O
∼70	O
%	O
accuracy	O
)	O
and	O
quantitative	O
IC50	O
predictions	O
(	O
RMSE	O
∼	O
1	O
log	O
)	O
.	O

The	O
success	O
of	O
the	O
2D	B:C1705052
descriptor	B:C0282354
based	O
machine	O
learning	O
approach	B:C0449445
when	O
compared	O
against	O
the	O
3D	B:C0450363
field	I:C0450363
based	O
technique	O
pursued	O
for	O
hBACE	B:C1569775
-	I:C1569775
1	I:C1569775
inhibitors	B:C0243077
provides	O
a	O
strong	O
impetus	O
for	O
systematically	O
applying	O
such	O
methods	B:C0025663
during	O
the	O
lead	B:C0243095
identification	I:C0243095
and	O
optimization	O
efforts	O
for	O
other	O
protein	B:C1335532
families	I:C1335532
as	O
well	O
.	O

